David P. Al-Adra, MD, PhD, FACS

Assistant Professor

  • Division of Transplantation 

aladra@surgery.wisc.edu
(608) 263-0388

Clinical Science Center
600 Highland Avenue
Madison WI 53792

Education

  • MD, University of Alberta, 2007
  • PhD, Clinical Investigator Program in the Department of Surgery, University of Alberta, 2012
  • Residency, General Surgery, University of Alberta, 2015
  • Abdominal Organ Transplant Fellowship, University of Toronto, 2017

Clinical Specialties

Dr. Al-Adra is certified by the American Board of Surgery (ABS), the American Society of Transplant Surgeons (ASTS), the Royal College of Surgeons of Canada, and the Americas Hepato-Pancreato-Biliary Association (AHPBA). He specializes in liver, kidney, pancreas and pediatric transplantation, live donor liver transplantation (LDLT), and hepatobiliary surgery.

Research Interests

Dr. Al-Adra is investigating the mechanisms of immunological rejection after solid organ transplantation. The goal of his research is to decrease the immune response against the organ, which would then decrease the need for anti-rejection drugs. Specifically, the transplanted organs can be modified using normothermic machine organ preservation technologies to decrease rejection after transplantation.

Learn more about Dr. Al-Adra’s lab here. 

Recent Publications

  • Microwave ablation as bridging to liver transplant for patients with hepatocellular carcinoma: a single-center retrospective analysis.
    Couillard AB, Knott EA, Zlevor AM, Mezrich JD, Cristescu MM, Agarwal P, Ziemlewicz TJ, Longhurst C, Lubner MG, Hinshaw JL, Said A, Laeseke PF, Lucey MR, Rice JP, Foley D, Al-Adra D, Lee FT
    J Vasc Interv Radiol 2022 Jun 03;
    [PubMed ID: 35667580]

  • Post-pancreatic transplant enteric leaks: The role of the salvage operation.
    Fleetwood VA, Falls C, Ohman J, Aziz A, Stalter L, Leverson G, Welch B, Kaufman DB, Al-Adra DP, Odorico JS
    Am J Transplant 2022 May 20;
    [PubMed ID: 35593379]

  • RNA sequencing analysis of hepatocellular carcinoma identified oxidative phosphorylation as a major pathologic feature.
    Liu Y, Al-Adra DP, Lan R, Jung G, Li H, Yeh MM, Liu YZ
    Hepatol Commun 2022 Mar 28;
    [PubMed ID: 35344307]

  • Single-cell RNA sequencing distinguishes dendritic cell subsets in the rat, allowing advanced characterization of the effects of FMS-like tyrosine kinase 3 ligand.
    Carlson KN, Verhagen JC, Jennings H, Verhoven B, McMorrow S, Pavan-Guimaraes J, Chlebeck P, Al-Adra DP
    Scand J Immunol 2022 Mar 14; e13159
    [PubMed ID: 35285040]

  • Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care.
    Pillai AA, Kriss M, Al-Adra DP, Chadha RM, Cushing MM, Farsad K, Fortune BE, Hess AS, Lewandowski R, Nadim MK, Nydam T, Sharma P, Karvellas CJ, Intagliata N
    Liver Transpl 2022 Mar 07;
    [PubMed ID: 35253365]

All Publications on PubMed